|
Market Closed -
Nasdaq
04:00:00 2026-10-30 pm EDT
|
5-day change | 1st Jan Change | ||
| 15.19 USD | -0.52% |
|
+9.83% | - |
| Market Cap | 693M 621M 571M 518M 968M 65.84B 986M 6.81B 2.73B 34.64B 2.6B 2.55B 109B | P/E 2026 * |
-5.47x | P/E 2027 * | -7.25x |
|---|---|---|---|---|---|
| Enterprise Value | 314M 282M 259M 235M 439M 29.86B 447M 3.09B 1.24B 15.71B 1.18B 1.16B 49.54B | EV / Sales 2026 * |
680x | EV / Sales 2027 * | - |
| Free-Float |
90.95% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATTO | Delayed | |
CBOE
| ATTO | Real-time |
Last Transcript: Attovia Therapeutics, Inc.
| 1 day | -0.52% | ||
| 1 week | +9.83% | ||
| Current month | -11.38% | ||
| 1 month | -11.38% |
| 1 week | 13.62 |  | 16.83 |
| 1 month | 12.94 | | 18.5 |
| Current year | 12.94 | | 28 |
| 1 year | 12.94 | | 28 |
| 3 years | 12.94 | | 28 |
| 5 years | 12.94 | | 28 |
| 10 years | 12.94 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 2022-12-15 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 2023-05-31 |
Tao Fu
CEO | Chief Executive Officer | 54 | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 2023-05-31 |
Tao Fu
BRD | Director/Board Member | 54 | 2023-03-31 |
James Topper
CHM | Chairman | 64 | 2023-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/6/26 | Goldman Sachs & Co. LLC (Private Banking)
| Conversion | Company | 25,562,737 | 59.4081% | |
| 8/6/26 | Conversion | 1,865,710 | 4.3359% | |||
| 8/6/26 | Deep Track Capital LP
| Conversion | Company | 20,138,956 | 46.8032% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | +9.83% | - | - | 693M | |
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | |
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | |
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | |
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | |
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | |
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | |
| Average | +0.25% | +7.77% | +47.86% | +206.32% | 39.5B | |
| Weighted average by Cap. | +0.18% | +5.45% | +48.50% | +186.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 462K 414K 381K 345K 645K 43.91M 657K 4.54M 1.82M 23.1M 1.74M 1.7M 72.85M | - |
| Net income | -83.44M -74.73M -68.74M -62.28M -116M -7.92B -119M -820M -329M -4.17B -313M -306M -13.14B | -107M -95.96M -88.27M -79.98M -149M -10.17B -152M -1.05B -423M -5.35B -402M -394M -16.88B |
| Net Debt | -379M -339M -312M -283M -529M -35.98B -539M -3.72B -1.49B -18.93B -1.42B -1.39B -59.69B | -286M -256M -236M -214M -399M -27.17B -407M -2.81B -1.13B -14.29B -1.07B -1.05B -45.06B |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | $15.19 | -0.52% | 146,673 |
| 26-10-29 | $15.27 | -3.35% | 413,809 |
| 26-10-28 | $15.80 | +5.33% | 174,511 |
| 26-10-27 | $15.00 | +8.07% | 454,269 |
| 26-10-26 | $13.88 | +0.36% | 224,637 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.19USD
Average target price
42.20USD
Spread / Average Target
+177.81%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
